The coronavirus disease 2019 (COVID-19) pandemic caused by a novel strain of the viral family (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) has highlighted the need for novel treatment options. However, novel treatments are often offered using noncentralized data from small or anecdotal studies, with regimens for these treatments varying on an institutional basis. Therefore,…
All articles by Natasha Priya Dyal, MD
Approximately 1 in 5 people with HIV also has prevalent DM, and control of hemoglobin A1c levels in these patients may have a beneficial effect on CD4 counts.